CONMED Corporation (CNMD)
Return on equity (ROE)
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 64,071 | 110,196 | 118,751 | 132,424 | 131,740 | 98,593 | 82,349 | 64,459 | 57,972 | 88,285 | -93,738 | -80,582 | -82,722 | -113,924 | 67,657 | 62,542 | 62,238 | 54,140 | 13,450 | 9,517 |
| Total stockholders’ equity | US$ in thousands | 1,008,260 | 1,002,870 | 977,636 | 962,681 | 932,896 | 881,832 | 854,664 | 834,222 | 796,205 | 780,194 | 752,453 | 745,545 | 716,337 | 672,968 | 789,546 | 785,435 | 755,683 | 744,499 | 725,570 | 709,038 |
| ROE | 6.35% | 10.99% | 12.15% | 13.76% | 14.12% | 11.18% | 9.64% | 7.73% | 7.28% | 11.32% | -12.46% | -10.81% | -11.55% | -16.93% | 8.57% | 7.96% | 8.24% | 7.27% | 1.85% | 1.34% |
September 30, 2025 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $64,071K ÷ $1,008,260K
= 6.35%
Peer comparison
Sep 30, 2025
Company name
Symbol
ROE
CONMED Corporation
CNMD
6.35%
Abbott Laboratories
ABT
27.43%
Stryker Corporation
SYK
14.48%